• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳糜泻患者经麸质激发后细胞因子释放与胃肠道症状。

Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease.

机构信息

Division of Gastroenterology and Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA, USA.

Immunology Division, The Walter and Eliza Hall Institute, Parkville, VIC, Australia.

出版信息

Sci Adv. 2019 Aug 7;5(8):eaaw7756. doi: 10.1126/sciadv.aaw7756. eCollection 2019 Aug.

DOI:10.1126/sciadv.aaw7756
PMID:31457091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6685723/
Abstract

Celiac disease (CeD), caused by immune reactions to cereal gluten, is treated with gluten -elimination diets. Within hours of gluten exposure, either perorally or extraorally by intradermal injection, treated patients experience gastrointestinal symptoms. To test whether gluten exposure leads to systemic cytokine production time -related to symptoms, series of multiplex cytokine measurements were obtained in CeD patients after gluten challenge. Peptide injection elevated at least 15 plasma cytokines, with IL-2, IL-8, and IL-10 being most prominent (fold-change increase at 4 hours of 272, 11, and 1.2, respectively). IL-2 and IL-8 were the only cytokines elevated at 2 hours, preceding onset of symptoms. After gluten ingestion, IL-2 was the earliest and most prominent cytokine (15-fold change at 4 hours). Supported by studies of patient-derived gluten-specific T cell clones and primary lymphocytes, our observations indicate that gluten-specific CD4 T cells are rapidly reactivated by antigen -exposure likely causing CeD-associated gastrointestinal symptoms.

摘要

乳糜泻(CeD)是由对谷物麸质的免疫反应引起的,其治疗方法是采用无麸质饮食。在食用麸质后的数小时内,无论是经口摄入还是通过皮内注射摄入,接受治疗的患者都会出现胃肠道症状。为了测试麸质暴露是否会导致与症状相关的全身性细胞因子产生,在麸质挑战后对 CeD 患者进行了一系列多重细胞因子测量。肽注射至少升高了 15 种血浆细胞因子,其中 IL-2、IL-8 和 IL-10 最为突出(4 小时时的倍数增加分别为 272、11 和 1.2)。IL-2 和 IL-8 是仅在 2 小时升高的细胞因子,早于症状发作。在摄入麸质后,IL-2 是最早和最突出的细胞因子(4 小时时增加 15 倍)。这些观察结果得到了患者来源的麸质特异性 T 细胞克隆和原代淋巴细胞研究的支持,表明麸质特异性 CD4 T 细胞可能通过抗原暴露而被迅速重新激活,从而导致 CeD 相关的胃肠道症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72e1/6685723/bc6d1ff5d0e6/aaw7756-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72e1/6685723/639901f17403/aaw7756-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72e1/6685723/9534835d7e94/aaw7756-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72e1/6685723/bc6d1ff5d0e6/aaw7756-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72e1/6685723/639901f17403/aaw7756-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72e1/6685723/9534835d7e94/aaw7756-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72e1/6685723/bc6d1ff5d0e6/aaw7756-F3.jpg

相似文献

1
Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease.乳糜泻患者经麸质激发后细胞因子释放与胃肠道症状。
Sci Adv. 2019 Aug 7;5(8):eaaw7756. doi: 10.1126/sciadv.aaw7756. eCollection 2019 Aug.
2
A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease.一种敏感的全血检测方法可检测 CD4+ T 细胞对刺激原的细胞因子释放,有助于评价在乳糜泻患者中进行的 Nexvax2 的 2 期临床试验中的免疫监测。
Front Immunol. 2021 May 19;12:661622. doi: 10.3389/fimmu.2021.661622. eCollection 2021.
3
Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease.低 FODMAP 掩蔽性速发麸质挑战可引发恶心和呕吐,这是与治疗后乳糜泻免疫激活相关的关键症状。
Aliment Pharmacol Ther. 2020 Jan;51(2):244-252. doi: 10.1111/apt.15551. Epub 2019 Nov 26.
4
Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.针对乳糜泻中 CD4 阳性 T 细胞的表位特异性免疫治疗:在一项随机、双盲、安慰剂对照的 1 期研究中,递增剂量的 Nexvax2 的安全性、药代动力学以及对肠道组织学和血浆细胞因子的影响。
EBioMedicine. 2017 Dec;26:78-90. doi: 10.1016/j.ebiom.2017.11.018. Epub 2017 Nov 22.
5
CD38 expression on gluten-specific T cells is a robust marker of gluten re-exposure in coeliac disease.在乳糜泻中,麦胶特异性 T 细胞上的 CD38 表达是 gluten 再暴露的强有力标志物。
United European Gastroenterol J. 2019 Dec;7(10):1337-1344. doi: 10.1177/2050640619874183. Epub 2019 Sep 7.
6
Plasma IL-2 and Symptoms Response after Acute Gluten Exposure in Subjects With Celiac Disease or Nonceliac Gluten Sensitivity.乳糜泻或非乳糜泻麸质敏感性患者急性麸质暴露后血浆白介素 2 与症状反应。
Am J Gastroenterol. 2022 Feb 1;117(2):319-326. doi: 10.14309/ajg.0000000000001565.
7
Evaluating Responses to Gluten Challenge: A Randomized, Double-Blind, 2-Dose Gluten Challenge Trial.评估对 gluten challenge 的反应:一项随机、双盲、2 剂量 gluten challenge 试验。
Gastroenterology. 2021 Feb;160(3):720-733.e8. doi: 10.1053/j.gastro.2020.10.040. Epub 2020 Oct 29.
8
Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity.进食麸质后细胞因子的释放可区分乳糜泻与自述的麸质敏感性。
United European Gastroenterol J. 2020 Feb;8(1):108-118. doi: 10.1177/2050640619874173. Epub 2019 Sep 3.
9
Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease.乳糜泻中麸质介导的细胞因子释放期间血清细胞因子升高。
Clin Exp Immunol. 2020 Jan;199(1):68-78. doi: 10.1111/cei.13369. Epub 2019 Oct 1.
10
Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease.血清白细胞介素-2 升高与麸质相关,与症状相关,是乳糜泻的潜在诊断生物标志物。
Aliment Pharmacol Ther. 2019 Oct;50(8):901-910. doi: 10.1111/apt.15477. Epub 2019 Sep 4.

引用本文的文献

1
A laboratory test to detect gliadin-specific CD4 T-cells for difficult to diagnose celiac disease.一种用于检测麸质特异性CD4 T细胞以诊断疑难乳糜泻的实验室检测方法。
J Transl Autoimmun. 2025 Jul 24;11:100301. doi: 10.1016/j.jtauto.2025.100301. eCollection 2025 Dec.
2
Comprehensive Overview of Cytokine Interplay in Vitiligo: A Decade of Meta-Analyses Systematically Reviewed.白癜风中细胞因子相互作用的综合概述:对十年荟萃分析的系统评价
Life (Basel). 2025 Apr 23;15(5):684. doi: 10.3390/life15050684.
3
Immune-epithelial-stromal networks define the cellular ecosystem of the small intestine in celiac disease.

本文引用的文献

1
Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.在乳糜泻患者的炎症性肠组织中,浆细胞是表达 MHC 的最丰富的麦胶肽细胞。
Gastroenterology. 2019 Apr;156(5):1428-1439.e10. doi: 10.1053/j.gastro.2018.12.013. Epub 2018 Dec 26.
2
Biology and regulation of IL-2: from molecular mechanisms to human therapy.IL-2 的生物学和调控:从分子机制到人体治疗。
Nat Rev Immunol. 2018 Oct;18(10):648-659. doi: 10.1038/s41577-018-0046-y.
3
Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.
免疫-上皮-基质网络界定了乳糜泻中小肠的细胞生态系统。
Nat Immunol. 2025 May 6. doi: 10.1038/s41590-025-02146-2.
4
Celiac Disease-Narrative Review on Progress in Celiac Disease.乳糜泻——乳糜泻进展的叙述性综述
Foods. 2025 Mar 11;14(6):959. doi: 10.3390/foods14060959.
5
Review Article: Novel Enzyme Therapy Design for Gluten Peptide Digestion Through Exopeptidase Supplementation.综述文章:通过补充外肽酶设计用于消化麸质肽的新型酶疗法
Aliment Pharmacol Ther. 2025 Apr;61(7):1123-1139. doi: 10.1111/apt.70014. Epub 2025 Feb 16.
6
Celiac Disease: A Transitional Point of View.乳糜泻:一种过渡性观点。
Nutrients. 2025 Jan 10;17(2):234. doi: 10.3390/nu17020234.
7
Beyond the gluten-free diet: Innovations in celiac disease therapeutics.超越无麸质饮食:乳糜泻治疗的创新。
World J Gastroenterol. 2024 Oct 14;30(38):4194-4210. doi: 10.3748/wjg.v30.i38.4194.
8
Exopeptidase combination enhances the degradation of isotopically labelled gluten immunogenic peptides in humans.外肽酶组合增强了放射性标记的谷蛋白免疫原性肽在人体中的降解。
Front Immunol. 2024 Oct 16;15:1425982. doi: 10.3389/fimmu.2024.1425982. eCollection 2024.
9
The role of IL-37 in gastrointestinal diseases.IL-37 在胃肠道疾病中的作用。
Front Immunol. 2024 Aug 14;15:1431495. doi: 10.3389/fimmu.2024.1431495. eCollection 2024.
10
Evolution in coeliac disease diagnosis and management.乳糜泻诊断与管理的进展
JGH Open. 2024 Jul 2;8(7):e13107. doi: 10.1002/jgh3.13107. eCollection 2024 Jul.
针对乳糜泻中 CD4 阳性 T 细胞的表位特异性免疫治疗:在一项随机、双盲、安慰剂对照的 1 期研究中,递增剂量的 Nexvax2 的安全性、药代动力学以及对肠道组织学和血浆细胞因子的影响。
EBioMedicine. 2017 Dec;26:78-90. doi: 10.1016/j.ebiom.2017.11.018. Epub 2017 Nov 22.
4
HLA-DQ:gluten tetramer test in blood gives better detection of coeliac patients than biopsy after 14-day gluten challenge.HLA-DQ:血液中的 gluten tetramer 检测比 14 天 gluten 挑战后的活检更能检测出乳糜泻患者。
Gut. 2018 Sep;67(9):1606-1613. doi: 10.1136/gutjnl-2017-314461. Epub 2017 Aug 4.
5
Coeliac disease.乳糜泻
Lancet. 2018 Jan 6;391(10115):70-81. doi: 10.1016/S0140-6736(17)31796-8. Epub 2017 Jul 28.
6
Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.针对乳糜泻中 CD4 阳性 T 细胞的表位特异性免疫治疗:两项随机、双盲、安慰剂对照的 1 期研究。
Lancet Gastroenterol Hepatol. 2017 Jul;2(7):479-493. doi: 10.1016/S2468-1253(17)30110-3. Epub 2017 May 11.
7
T Cells in Celiac Disease.乳糜泻中的T细胞
J Immunol. 2017 Apr 15;198(8):3005-3014. doi: 10.4049/jimmunol.1601693.
8
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.制瘤素M可引发肠道炎症,并预测炎症性肠病患者对肿瘤坏死因子中和疗法的反应。
Nat Med. 2017 May;23(5):579-589. doi: 10.1038/nm.4307. Epub 2017 Apr 3.
9
Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial.尽管采用无麸质饮食,醋酸兰瑞肽治疗乳糜泻持续症状的随机对照试验。
Gastroenterology. 2015 Jun;148(7):1311-9.e6. doi: 10.1053/j.gastro.2015.02.008. Epub 2015 Feb 13.
10
Tetramer-visualized gluten-specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge.血液中四聚体可视化的麦胶蛋白特异性 CD4+T 细胞可作为不经口麸质激发的乳糜泻潜在诊断标志物。
United European Gastroenterol J. 2014 Aug;2(4):268-78. doi: 10.1177/2050640614540154.